RVA48079, 516480-79-8, Chk2 Inhibitor II

RVA48079, 516480-79-8, Chk2 Inhibitor II

APExBIO - TAK-242, TLR 4 signaling inhibitor

Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies

HY-13740-100mg Resiquimod [144875-48-9] Clinisciences

Cdk1/2 Inhibitor III ( Cyclin-dependent kinase 1/2 Inhibitor​ III, CAS Number: 443798-47-8)

Adaptec ASR-6405 512MB RAID Controller Card PCIe x8 SAS 2.0 Raid Controller

NVP 2 (CAS 1263373-43-8): R&D Systems

Chk2 Inhibitor, PV1019 The Chk2 Inhibitor, PV1019 controls the biological activity of Chk2. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

Chk2 Inhibitor II

HY-13740-100mg Resiquimod [144875-48-9] Clinisciences

APExBIO - TAK-242, TLR 4 signaling inhibitor

APExBIO - SCH772984, ERK1 and ERK2 inhibitor

Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly, Molecular Cancer

Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer